Task: Answer the multiple-choice question.
Query: Which drug exhibits a -1.718\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) CCCCn1c(Cc2ccccc2)nnc1SCC(=O)N1CCOCC1
(b) Cn1c(CNC(=O)c2ccccc2F)nnc1SCCOc1ccccc1
(c) COc1ccc(C)cc1NC(=O)CCNC(=O)c1ccco1
Answer: a. CCCCn1c(Cc2ccccc2)nnc1SCC(=O)N1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCn1c(Cc2ccccc2)nnc1SCC(=O)N1CCOCC1
CCCCn1c(Cc2ccccc2)nnc1SCC(=O)N1CCOCC1
2-[(5-benzyl-4-butyl-1,2,4-triazol-3-yl)sulfanyl]-1-morpholin-4-ylethanone